24/7 Live
Los Angeles
Orange County
Inland Empire
Ventura County
California
Welcome, Mickey
mickey@disney.com
Manage MyDisney Account
Log Out
Weather Alert
Fire Weather Watch
High Surf Warning
Coastal Flood Advisory
Freeze Warning
Palisades Fire
Eaton Fire
Resources
En EspaƱol
7 On Your Side
Investigates
Submit News Tips
weight loss
Share
Tweet
Email
FDA approves 1st medication for obstructive sleep apnea
The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.
US obesity rates drop for 1st time in a decade
Jelly Roll's chef opens up about singer's 100-pound weight loss
Ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's: Study
Weight loss drugs like Ozempic may help reduce overdose risks: Study
Ozempic producer CEO in hot seat in congressional hearing
Obesity prevalence among US adults falls slightly to 40%: CDC
More Stories
Eli Lilly to sell Zepbound directly to consumers without insurance
Some people are overdosing on semaglutide, FDA warns
Nearly half of US adult cancer deaths could be prevented, study finds
Pfizer targets obesity with new once-daily Danuglipron drug
Eli Lilly warns about dangers of fake Mounjaro, Zepbound
New Wegovy clinical trial finds surprising benefits beyond weight loss
Ricki Lake opens up after weight loss: 'This is what happy looks like'
Barbra Streisand asks Melissa McCarthy about Ozempic, sparking debate
Sanders launches Senate investigation into price of Ozempic, Wegovy
Weight loss drug shortages | What it means for patients
Weight loss drug could soon treat types of sleep apnea, drugmaker says
'Oat-zempic' trend 'does not mimic' Ozempic's effects, experts says
Show More
Show Fewer
More Stories
US obesity rates drop for 1st time in a decade
Jelly Roll's chef opens up about singer's 100-pound weight loss
Ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's: Study
Weight loss drugs like Ozempic may help reduce overdose risks: Study
Ozempic producer CEO in hot seat in congressional hearing
Obesity prevalence among US adults falls slightly to 40%: CDC
Eli Lilly to sell Zepbound directly to consumers without insurance
Some people are overdosing on semaglutide, FDA warns
Nearly half of US adult cancer deaths could be prevented, study finds
Pfizer targets obesity with new once-daily Danuglipron drug
Eli Lilly warns about dangers of fake Mounjaro, Zepbound
New Wegovy clinical trial finds surprising benefits beyond weight loss
Ricki Lake opens up after weight loss: 'This is what happy looks like'
Barbra Streisand asks Melissa McCarthy about Ozempic, sparking debate
Sanders launches Senate investigation into price of Ozempic, Wegovy
Weight loss drug shortages | What it means for patients
Weight loss drug could soon treat types of sleep apnea, drugmaker says
'Oat-zempic' trend 'does not mimic' Ozempic's effects, experts says
Show More
Show Fewer